Viral inhibitors

The present invention relates to a derivatised amphiphilic carbohydrate compound with molecular weight less than 50 kDa which is based on a glycol chitosan for use in the prevention or treatment of a viral infection. The invention further relates to the use of the compound when formulated with other...

Full description

Saved in:
Bibliographic Details
Main Authors MILEWSKA, Aleksandra, SCHATZLEIN, Andreas, PYRC, Krzysztof, UCHEGBU, Ijeoma, BARRETO DURAN, Emilia
Format Patent
LanguageEnglish
Published 23.03.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a derivatised amphiphilic carbohydrate compound with molecular weight less than 50 kDa which is based on a glycol chitosan for use in the prevention or treatment of a viral infection. The invention further relates to the use of the compound when formulated with other components in pharmaceutical compositions for the prevention or treatment of viral infections, and further to a method of reducing viral replication in human tissues.
Bibliography:Application Number: AU20210333748